More importantly, the tumor-suppressive effects of DSCR9 overexpression on pancreatic cancer cells were significantly reversed by miR-21-5p overexpression, whereas the suppressive effects of DSCR9 overexpression on BTG2 expression were reversed by miR-21-5p overexpression. This evidence concerns the gene DSCR9 and pancreatic neoplasm.